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CHAPTER 1 : INTRODUCTION  
1.1 Research Background 
Sikich and Lerman (2004) defined emergence delirium as “a disturbance in a 
patient’s awareness of and attention to his or her environment with disorientation and 
perceptual alterations, including hypersensitivity to stimuli and hyperactive motor 
behaviour in the immediate postanaesthesia period.” In most literature, emergence 
agitation and emergence delirium have been used conversely. Emergence agitation is 
not a new clinical phenomenon, with various predisposing factors and effects; 
however, it is of more importance recently because its increasing incidence seem to 
coincide with more widespread use of sevoflurane in recent years.  
Other possible known causes of emergence agitation are pain, preoperative 
anxiety, type of surgical procedures, personal characteristics of the patient and type of 
anaesthetics. However, the exact cause and mechanism is still unknown.  
Emergence agitation at the end of anaesthesia may make the anaesthetist look 
bad and seemingly lacking of experience or skill, just like a pilot who had just made a 
rough landing of a plane. It can cause distress for the anaesthetist and nursing team, 
resulted in more manpower required in the recovery unit and can hamper proper 
postoperative monitoring and management. More seriously, it can result in dangerous 
consequences too such as suture dehiscence, bleeding, increased pain, hypertension 
and increased intracranial pressure, self extubation, accidental removal of catheters 
and drains, and also injury to the patient’s self and to staff.  
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Drugs such as analgesics, opioids, benzodiazepines, clonidines and 
dexmedetomidine have been used either prophylactically or as a treatment for 
emergence agitation with variable success (Isik et al., 2006). 
 
1.2 Rationale of Study 
Due to the problems and complications from emergence agitation as 
mentioned, it is a concern that methods to reduce the incidence of emergence 
agitation be researched and applied.  
This study is to evaluate the benefits, if any, of dexmedetomidine to reduce or 
prevent emergence agitation and to determine the possibility and the severity of its 
side effects when used as an infusion intraoperatively. Drugs such as analgesics, 
opioids, benzodiazepines, clonidines also had been studied before but these drugs are 
less practical to be used in this setting as they have respiratory depressant effects and 
may cause delayed awakening from general anaesthesia. 
Usage of a specific drug as prevention for emergence agitation is still not a 
common practice in our routine of anaesthesia. If it is proven to be beneficial and safe, 
this practice should be encouraged and implemented in our general anaesthesia 
regime, particularly for those with high risk of serious sequelae from emergence 
agitation such as tonsillectomy, corneal implants and neurosurgery patients, and also 
patients with cardiac diseases and hyper reactive airways. Studying the risk factors for 
emergence agitation may enlighten us of the high risk group for us to anticipate and 
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treat pre-emptively. We suggest that emergence agitation be addressed and treated 
equally the way we usually anticipate and pre-emptively treat other common 
anaesthetic problems such as postoperative pain or postoperative nausea and 
vomiting. 
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CHAPTER 2 : LITERATURE REVIEW 
2.1 Emergence from Anaesthesia 
Darren et al. (2014) defined emergence as the wake-up period following 
withdrawal of general anaesthetic, the period from the cessation of general 
anaesthetic agents until the patient is able to make a non-reflex response to verbal 
command. 
There has been an increasing interest in anaesthetic emergence and the 
neurobiological processes leading to the return of consciousness over the last decade. 
Patients characteristics and changes that take place during emergence has captivated 
the attention of researches who tried to unravel the mystery of emergence from the 
neural correlates of consciousness to clinical oriented studies such as patient’s quality 
of recovery and factors that can affect them. Apart from scientific interest, studies 
regarding emergence from anaesthesia has been gaining popularity with the aim to 
improve the clinical course during anaesthesia, particularly during emergence as it is a 
fact that emergence is an important phase, whereby major life-threatening 
complications can occur such as bronchospasm and bronchial asthma, severe 
hypertension, intracranial bleed and myocardial infarction if it is not handled well. A 
smooth and an uneventful emergence should be one of the main aims of anaesthetists 
conducting general anaesthesia in the operating theatre.  
 When a patient is induced to loss of consciousness through anaesthesia, he or 
she goes through several stages. At a small dose, anaesthetics first suppress thinking, 
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focused attention, and working memory. As the dose is increased, consciousness and 
voluntary responsiveness begin to fade. When subjects no longer respond to verbal 
stimulation, it is presumed that their consciousness is gone. This is a conjecture 
supported by the loss of episodic memory of the stimuli, but does not define the 
residual mental contents of the subject at the time of stimulation. As the anaesthetic 
dose is increased, nociceptive and autonomic reflexes are suppressed. The latter are 
mediated at the brainstem and spinal level and are thought to occur after the loss of 
consciousness. At even higher dose, brain electrical activity is turned into intermittent, 
and ultimately, complete suppression. For the time being, loss of consciousness will be 
operationally defined as a loss of voluntary responsiveness, excluding limiting factors 
such as the use of muscle relaxants, the presence of motor impairment, or akinetism. 
At an anesthetic depth characterized by the subjects' unresponsiveness, a partial, but 
not complete, reduction in connectivity is generally observed. Functional connectivity 
of the frontoparietal association cortex is often reduced, but a causal role of this 
change for the loss of consciousness remains uncertain. Functional connectivity of the 
nonspecific (intralaminar) thalamic nuclei is preferentially reduced by propofol. Higher-
order thalamocortical connectivity is also reduced with certain anesthetics. 
Anaesthetic loss of consciousness is not a block of corticofugal information transfer, 
but a disruption of higher-order cortical information integration. (Hudetz, 2012). 
Multiple neurotransmitter system contribute to wakefulness, however none 
functions as a sole player. They are interconnected to each other to form an excitatory 
network and act with interactions before projecting to the cortex. Among the 
neurotransmitter system that are involved are the cholinergic (acetylcholine) basal 
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forebrain, orexinergic lateral hypothalamic, serotonergic raphe, noradrenergic locus 
coeruleus, and histaminergic tuberomammillary neurons. These neurotransmitters are 
involved in the mechanism of anaesthesia, during induction, maintenance and 
emergence (Muller et al., 2011). 
Previously, there was a common belief that emergence from anaesthesia is the 
inverse or mirror process of induction, brought about simply by elimination of 
anaesthetic drugs from their sites of action in the central nervous system. However, 
recent studies had proven that emergence from anaesthesia is a unique process by 
itself, a process with a distinct neurobiology characteristics from anaesthesia or loss of 
consciousness. 
Firstly, from neuroimaging, it can be seen that different areas in the brain is 
activated during induction of anaesthesia (loss of consciousness) and emergence. A 
human study with positron emission tomography indicated several brain regions are 
activated in the consciousness state. The regions are the anterior cingulate cortex in 
the medial frontal lobe, the midline thalamus, hypothalamus, the locus coeruleus or 
parabrachial area in the brainstem, the cerebellum, and portions of the lateral orbital 
frontal and parietal lobes. When the subjects are conscious, functional connectivity 
exists between the frontal and parietal brain areas, but that connectivity fades in 
conjunction with loss of consciousness from anaesthetics. The return to consciousness 
was not associated with a significant restoration of cortical activation. In fact, arousal 
induced activations were mostly localized in deep, phylogenetically old brain 
structures rather than in the neocortex (Langsjo et al., 2012). 
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Kelz and colleagues in a study published in 2008 mentioned that there are 
important differences in the neural substrates mediating induction and emergence. 
They studied the role of the endogenous orexinergic system in impacting from, but not 
entry into the anaesthetized state. From their study, they demonstrated that 
isoflurane and sevoflurane, two commonly used general anesthetics, inhibit c-Fos 
expression in orexinergic but not adjacent melanin-concentrating hormone neurons; 
suggesting that wake-active orexinergic neurons are inhibited by these anesthetics. 
Genetic ablation of orexinergic neurons, which causes acquired murine narcolepsy, 
delays emergence from anesthesia, without changing anesthetic induction. By this 
they were able to distinguish the mechanisms of induction from those of emergence. 
Thus the newer concept that emergence also depends on recruitment and stabilization 
of wake-active region in the brain.  
A study done by Hudetz et al. in 2012 also supports the theory that emergence 
is an active process altogether, not merely a reverse process from anaesthesia or 
losing of consciousness. In this study, a substantial asymmetry in regional 
thalamocortical functional connectivity was observed during wakefulness before and 
after propofol sedation was given. After the participants had regained consciousness, 
they demonstrated that the functional connectivity of several thalamocortical 
networks was increased well above the preanesthetic baseline. Thus, this was 
interpreted as a probable recruitment of additional neural resources as required for 
the restoration of conscious functionalities of the brain. 
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2.2 Emergence Agitation. Definition. Background. Significance 
Emergence means liberation from or when a patient is awakening from the 
state of anaesthesia when at the end of surgery anaesthesia is no longer needed and 
terminated. Agitation is a condition where there is some form of restlessness and 
mental distress. Emergence agitation is first described in the 1960s, whereby children 
encounter a wide range of behavioural disturbances, including sobbing, crying, 
thrashing and disorientation when they had just emerged from anaesthesia. 
Emergence delirium can be defined as a state of mental confusion, agitation and 
disinhibition marked by hyperexcitability, crying, restlessness and hallucinations during 
emergence from general anaesthesia (Stamper et al., 2014). 
In the literatures, the terms emergence agitation and emergence delirium were 
used interchangeably. The reported prevalence of emergence agitation or delirium 
varies widely among the literature, ranging from 10% to 80% (Kwak, 2010). Numerous 
literatures mentioned that the problem with emergence agitation is the inadequate 
exact tool or objective method for assessing it. There are different scales available to 
measure agitation such as the Riker agitation-sedation scale, the Richmond sedation-
agitation scale and the New Sheffield sedation scale with the first two having excellent 
inter-rater reliability. However these scales are validated for use in the ICU and not 
validated in the recovery room or PACU (Yu et al., 2010). 
Ideally emergence should occur in a short time frame and in a smooth fashion, 
without the undesirable reaction from the patient and without unwanted side-effects 
from the residuals of the anaesthetics and their resultants in the physiology pertinent 
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to the anaesthetists which involve the airway, respiration, hemodynamics, autonomic, 
metabolic and endocrine functions. Though there has been better comprehension of 
arousal pathway in the nervous system along with the introduction of newer agents of 
anaesthetics and reversal plus modern monitoring systems resulting in faster and 
smoother emergence, anaesthetists still have challenges as patients’ responses to 
emergence are still widely variable with a number of predisposing factors (Bhaskar, 
2013). Furthermore, the underlying causes and the exact mechanisms of emergence 
agitation are still not clearly understood (Kwak, 2010). 
Emergence agitation can cause a huge stress for the anaesthetist and team, 
also for the patient and family. The failure to restrain and manage the patient in the 
agitated and sometimes uncontrolled situation added by the inability to comprehend it 
not only cause physiological distress to the anaesthetist but also poses risk of injury to 
the patient and also to the anaesthesia personnel (Lepouse et al., 2006; Sikich and 
Lerman, 2004). What could happen during this time is the patient may be pulling IV 
lines and drains, self extubate and causing self harm and other bodily injuries (Wofford 
& Vacchiano, 2011). It can also hamper proper monitoring and complicate 
management of the patients in the post anaesthesia care unit or recovery unit, 
requiring more staff for support (Voepel-Lweis et al., 2003). Seeing their loved ones in 
a very agitated state in the post-operative period may be terrifying for the family 
members as they may think that the patient had been through a difficult and 
problematic operation and anaesthesia. It is not easy on the family members too if 
they had to see the patient being put on physical restraint. 
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2.3 Causes and Risk Factors for Emergence Agitation 
There is no known definitive cause for emergence agitation. But there are 
possibilities that pain, preoperative anxiety, types of procedure, patient’s personality 
and characteristics, and anaesthetic types can explain emergence agitation, although 
there is no known sole determining factor (Vlajkovic & Sindjelic, 2007).  
Isoflurane, sevoflurane and desflurane are the newer gaseous anaesthetic 
agents that has been created to allow smoother and more predictable emergence due 
as they allow rapid titration of depth of anaesthesia compared to the older generation 
agents such as ether and halothane. However, with widespread usage of sevoflurane, 
there is reported increase in incidence of emergence agitation (Beskow & Westrin, 
1999). Also when compared to propofol, patient who had gets sevoflurane as 
anaesthetic had more incidence of emergence agitation (Kanaya et al., 2013). The 
characteristic of sevoflurane which has low blood solubility thus resulting in rapid 
removal is identified to be one of the mechanisms of emergence agitation caused by 
sevoflurane (Cravero et al., 2000). However, due to a superior elimination of propofol 
and remifentanil in terms of rapidity and completeness, patients received total 
intravenous anaesthesia have less emergent agitation compared to patients received 
general anaesthesia by inhalational agents 
Smessaert and colleagues construed two main causes for emergence agitation. 
The first one being anaesthetic cause (higher incidence in cyclopropane compared to 
ether or barbiturates) and the second one being surgical factor (higher incidence in 
peripheral surgery compared to intra-thoracic and intra-abdominal surgery). The 
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emergence agitation is more related to the patient’s characteristics (gender, age, 
mental attitude). A final hypothesis was made that rather than pain, the patient’s 
personality is the more important element that determines whether the patient will 
experience emergence agitation.  
There are a lot of studies about emergence from anaesthesia conducted and 
mostly showed that women recover faster than men and that there are differences in 
the post-operative recovery profile between the two sexes. Women have lighter 
anaesthetic states and faster recovery when compared to men, given the same 
amount of anaesthetic agents and opioid analgesic intra-operatively (Buchanan et al., 
2011). Sex hormones seem to have a role in modulating these differences. Estrogen, 
progesterone and androgen receptors have been recognised in brain which has roles 
different from reproductive functions. While progesterone has hypnotic effects via 
direct action on the GABA receptor, estrogen on the other hand suppresses this 
receptor resulting in opposite effect (Manber and Armitage, 1996). Furthermore, 
estrogen acts at NMDA-type glutamate receptors by increasing the excitatory 
transmission and increasing the affinity of glutamate to NMDA receptors (McEwen and 
Alves, 1999). These explain why women have more rapid emergent compared to men. 
However, more pertaining to emergence agitation (as it is often related to pain), there 
are difference in nociception in between male and females. Estrogen and 
progesterone had been observed to mediate and play a role in effecting excitability in 
brain and spinal cord (Woolley and Schwartzkroin, 1998). Though women have faster 
emergent, the quality is poorer due to higher pain scores (Buchanan et al., 2011). 
However there are different studies that showed the exact opposite. Men have lower 
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pain threshold compared to women (Tsui et al., 1996). And there is a higher incidence 
of emergence agitation in males, probability due to lower pain threshold. Pain is 
evidently one of the main cause of emergence agitation, as it showed that patients 
who were given adequate post-operative analgesia has lower incidence of emergent 
agitation compared to patients without post-operative analgesia (Yu et al., 2010).  
Type of surgical procedures also has an influence to the quality of emergent. 
Operations on the oral cavity and ENT are a risk factor for emergence agitation in 
children (Voepel-Lewis et al., 2003). It is speculated that head ENT surgery is related to 
emergence agitation as these patients feels suffocated during the emergent period 
(Eckenhoff, 1961). In a study by Lepouse et al. in 2006, it is found that emergence 
agitation is more common in abdominal and breast surgery.  
Inadequate reversal of muscle relaxant is also one of a known cause of 
emergence agitation in which patient wakes up with a feeling of suffocation and 
helplessness causing apprehensive behaviours. Others mentioned the presence of 
endotracheal tube and distended bladder when the patient wakes up as identified 
causes.  
Contradictory results had been yielded from previous studies regarding 
whether duration of anaesthesia influences emergent behaviour (Wells and Rasch, 
1999). Some studies observed that shorter duration of anaesthesia has higher 
incidence of emergence agitation, some studies found the opposite is true and some 
studies dictated that anaesthetic duration has no impact. It is postulated that shorter 
surgery allows rapid washout of anaesthetics from the body causing rapid emergence, 
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and emergence agitation resulted because effects of the analgesics given 
intraoperatively have yet to take peak effect (Rahil et al., 2012).  
Patients given midazolam preoperatively to alleviate anxiety had shown to have 
higher incidence of emergence agitation due to the paradoxical effect (Kudoh A et al., 
2004) while patients on antidepressants has a protection from delirium as these 
anxiolytics have a long half life. Patients who have history of medical illness and are 
accustomed to hospital environment found to have protective point against 
emergence agitation (Lepouse et al., 2006). 
Preoperative anxiety is an inconsistent risk factor for emergence delirium. A 
study done by Lepouse and colleagues in 2006 had found no correlation between 
preoperative anxiety and emergence agitation while Kain ZN and colleagues in their 
study conducted in 2004 among children undergoing surgery found that there is a 
relationship between anxiousness and emergence delirium. 
 
2.4 Prevention and Treatment for Emergence Agitation 
Simple actions such as removing endotracheal tube as early as possible and 
bladder drainage before patient wakes up, also explaining regarding various tubes and 
drainage that the patient may find him or herself connected to on waking up to reduce 
surprise and anxiety may reduce emergence agitation. Pain must be addressed, 
treated pre-emptively and aggressively (Lepouse et al. 2006).  
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There are many studies conducted regarding drug choices to tackle emergence 
agitation. Drugs that have been studied include fentanyl, propofol, clonidine and 
dexmedetomidine. Lee and colleagues in 2010 studied whether there is clinical benefit 
of propofol 1mg/kg given at the end of surgery in reducing the incidence and severity 
of emergence agitation in patients undergoing adenotonsillectomy, but they had found 
that it has no effect. Though as mentioned earlier that patients given TIVA propofol 
have better recovery profile and less occurrence of emergence agitation compared to 
patients who receive gaseous agents, the failure of propofol bolus given in this study 
to attenuate emergence agitation maybe attributed to the low dose (1mg/kg) and 
rapidly metabolised (Dahmani et al., 2010).  
Opioids have been investigated for their useful actions in smoothening 
emergence, but it mainly by suppressing cough that are seen during emergence when 
desflurane is used. For this, short acting opioids such as alfentanil and sulfentanil are 
used and they are given as a bolus dose at the end of surgery (Lee MG et al., 2011 and 
Lee JY et al., 2012). 
Benzodiazepines such as midazolam though given to patients to alleviate 
anxiety and expected to protect from delirium surprisingly increased the odds of 
emergence agitation. This is because they are known to have paradoxical effects and 
can cause irritability, aggressiveness and confusion (Kudoh et al., 2004). However there 
are studies that showed midazolam has benefit in reducing the incidence of 
emergence such as the one by Schor and colleagues in 1994. Thus, the effects of 
midazolam in curbing emergence agitation are not consistent. 
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Dexmedetomidine had been shown to have positive effects in reducing or 
prevent emergence agitation in various studies.  
 
2.5 Dexmedetomidine – A Review 
Dexmedetomidine is an imidazole compound which is a pharmacologically 
active dextroisomer of medetomidine (Savola and Virtanen, 1991). Dexmedetomidine 
is a potent α2-adrenoceptor agonist, the same with clonidine but with 8 times higher 
affinity. Its action is mediated through postsynaptic α2-adrenoreceptor that activate 
pertussis toxin sensititve G-proteins, resulting in increased conductance through 
potassium ion channel (Salonen et al., 1997). It is the α2-adrenoceptor that is 
responsible in relaying the properties of sedation and analgesia in dexmedetomidine.  
With a target plasma concentration of 0.6g/L, dexmedetomidine has a volume 
of distribution at steady state of 1.33L/kg and clearance of 0.495L/h/kg. Its distribution 
half-life is 6 minutes and elimination half-life is 2 hour. It is excreted mainly in the 
kidney (95%) as methyl and glucuronide conjugate (Nilla et al., 2000). 
Since its release in 1999, it had gained popularity in all age groups of patients 
that needs sedation, mostly because of its special feature of not causing respiratory 
depression, also due to its good profile in neuroprotection, cardioprotection and 
nephroprotection that had been proven in many studies (Chrysostomou and Schmitt, 
2008). Its main indication is for sedation of patients in ICU and shown to reduce the 
requirement of analgesics for post-operative patients. It has sedative, analgesia and 
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anxiolytic effects while maintaining arousability and cooperation, thus it is more 
known for its ability to produce ‘conscious sedation’ – a unique feature compared to 
other sedation such as propofol, benzodiazepines and opioids. In a phase I study, a 
dose dependent increase in sedation was seen with infusing dexmedetomidine for 24 
hours with target plasma concentrations of 0.3, 0.6 and 1.25mcg/L. Though there is 
differences of depth and duration of sedation between the groups, all healthy 
volunteers showed the same level of arousability and cooperation despite achieving 
clinically effective sedation (Morrison et al., 1991). In clinical trials too 
dexmedetomidine showed efficacy in providing sedation to patients. In two phase II 
studies, dexmedetomidine showed significant reduction of the need to give rescue 
sedation (midazolam and propofol) in postsurgical patients requiring ventilation and 
sedation (Bachand et al., 1999 and Martin et al., 1999). As for analgesic property, 
dexmedetomidine in the same studies done by Bachand and Martin in 1999 is found to 
reduce the need for rescue analgesic in postsurgical ICU patients requiring mechanical 
ventilation and sedation. In the study done also showed patients on dexmedetomidine 
are calmer and less anxious than their placebo counterparts. This anxiolysis effect of 
dexmedetomidine resulted in patients who are easier to manage.  
Among the pharmacodynamic effects of dexmedetomidine, 1mcg/kg infused 
over 2 minutes caused significant maximum reduction in heart rate and blood 
pressure, coinciding with reductions in plasma level of noradrenaline and adrenaline 
(Bloor et al., 1992). In 2 phase III trials with patients receiving dexmedetomidine 
infusion of 0.2-0.7mcg/kg/h, consistent reduction in mean blood pressure and heart 
rate seen, with return to baseline seen after 6 hours stopping infusion (Grounds 1999). 
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Dexmedetomidine 2mcg/kg infused over 2 minutes in healthy males resulted in slight 
increase in carbon dioxide partial pressure (reduction in about 5mmHg over 10 
minutes and gradually returned to normal after that) and decrease in minute 
ventilation (about 6-8L/min which occurred after 60 minutes). There was minimal 
change in respiratory rate. Respiratory depression is not an issue with 
dexmedetomidine. In phase 1 study, 24 hour infusion of dexmedetomidine with target 
plasma concentration of 0.3-1.25mcg/L did not result in respiratory depression in 
volunteers; with good oxygen saturation maintained seen. There is also no difference 
seen in the respiratory rate post extubation between dexmedetomidine and placebo 
group (Belleville et al., 1992).  
As of its side effects and tolerability, dexmedetomidine has a fairly good profile. 
In a phase III study done before, the most common side effects related to 
dexmedetomidine were hypotension, hypertension, nausea, bradycardia and dry 
mouth compared to placebo patients, who had reduced incidence of the mentioned 
side effects except for hypertension (Nilla et al., 2000). However, in most studies done 
previously, they are minimal, only occur in high infusion rates and usually counteracted 
successfully with resuscitating drugs. Such hemodynamic effects may be expected to 
be more pronounced and severe in hypovolaemic patients, in those with diabetes 
mellitus or chronic hypertension and in the elderly (Lee 2012). Dexmedetomidine also 
does not result in delayed recovery or prolonged extubation time (Kang et al., 2012). 
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2.6 Dexmedetomidine in Preventing Emergence Agitation 
Dexmedetomidine is widely used in the ICU setting. The use of it in the 
operating theatre setting and in patients undergoing surgery is not a current trend due 
to the concerns of intraoperative hemodynamic instability (bradycardia and 
hypotension) and postoperative delay in recovery (Lee, 2012). However, numerous 
studies had proven successful use of dexmedetomidine perioperatively for multiple 
objectives (e.g. attenuation of stress response of intubation, etc) without significant 
side effects, and this includes its use to prevent or attenuate emergence agitation. The 
stable intraoperative hemodynamics and postanaesthetic recovery speed that is 
acceptable are thought to be resulted not by the pharmacologic effect of 
dexmedetomidine but by its anaesthetics-sparing effect (Kang et al., 2012). 
In a study done by Kim and colleagues in 2013, intraoperative continuous 
dexmedetomidine infusion until extubation was effective in reducing the incidence of 
emergence agitation after nasal surgery without delay of extubation or increasing 
incidence of other complications.  
In children undergoing tonsillectomy and adenoidectomy, an intraoperative 
initial loading dose of 2mcg/kg dexmedetomidine followed by an infusion at 
0.7mcg/kg/h decreased intraoperative opiate and anaesthetic requirements and 
decreased opiate requirements in the PACU, compared to the control group receiving 
intraoperative IV fentanyl. Additionally, there was a significantly lower incidence and 
duration of severe emergence agitation in children who received dexmedetomidine 
(Patel et al., 2010). 
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A study was done by Kavalchi and colleagues and published recently in 2013 
comparing the effects of dexmedetomidine and remifentanil on emergence agitation 
after sevoflurane anaesthesia in adults undergoing septoplasty. In this study, both 
dexmedetomidine and remifentanil was given as infusion intraoperatively.  
Dexmedetomidine infusion dose was 0.4mcg/kg/hour after a loading dose of 1mcg/kg 
for 10 minutes given. The incidence of emergence agitation and postoperative pain 
score was similar between the 2 groups with stable hemodynamics intraoperatively. 
Children undergoing tonsillectomy experienced smoother emergence from 
general anaesthesia with better pain scores with infusion of 0.5mcg/kg of 
dexmedetomidine for 5 minutes before extubation when compared to placebo group. 
Lower frequency of airway difficulties was also noted in the dexmedetomidine group. 
This was attributed to the reduced laryngeal stimulation due to the sedative and 
analgesic effects of dexmedetomidine (Guler et al., 2005). In a similar study with the 
same paediatric population undergoing same surgery but with a lower 
dexmedetomidine infusion (0.3mcg/kg) also given 5 minutes prior to extubation, 
comparing it with propofol. It showed that dexmedetomidine was superior to propofol 
in reducing emergence agitation, postoperative pain score and extubation time, 
without affecting the length of stay in PACU (Monaz and Ashraf, 2013).  
Dexmedetomidine infusion of 0.2mcg/kg/h given to children aged 1-10 years 
undergoing surgery under sevoflurane anaesthesia when compared to saline placebo 
infusion showed lower incidence and frequency of emergence agitation with 
comparable extubation and discharge time (Shukry et al., 2005). 
22 
 
There was also a study comparing different infusion rates of dexmedetomidine. 
In a study by Ibacache and colleagues published in 2004, where dexmedetomidine was 
given as a single dose for 10 minutes after intubation in children undergoing superficial 
lower abdomen and genital surgery, it showed that a dose of 0.3mcg/kg reduced the 
incidence of emergence agitation better than 0.15mcg/kg group, and in both group 
lower incidence of emergence agitation seen when compared to the placebo group. 
General and intraoperative variables were similar and no side effects to 
dexmedetomidine were observed.  
There are many more studies done regarding the effects of dexmedetomidine 
in preventing or treating emergence agitation, with different modes of administration 
seen such as single dose after intubation, single dose just before extubation, infusion 
throughout operation and infusion with loading dose, also with different doses. Most 
of them showed success of dexmedetomidine in this term, with relatively safe profile 
of intraoperative hemodynamics in the lower doses range. Furthermore, 
dexmedetomidine showed superiority in regards to respiratory stability, extubation 
time and postoperative pain status compared to other agents such as opioids and 
propofol. 
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CHAPTER 3 : OBJECTIVES 
3.1 Primary Objective 
General objective 
 To investigate whether dexmedetomidine has positive effects in preventing 
emergence agitation in patients undergoing general anaesthesia 
Specific objective 
 To compare the incidence of emergence agitation between dexmedetomidine 
group and control (placebo) group 
3.2 Secondary Objectives 
 To evaluate whether the following are risk factors for emergence agitation 
o Patient’s demographic – Age, gender, race 
o Preoperative anxiety level 
o Duration of GA 
o Type of orthopaedic procedure 
 Superficial / soft tissue / muscle  
 Involving  bone structure 
 To observe the presence of side effects or complications of dexmedetomidine 
infusion during general anaesthesia 
 
